Phase II study of oral ENMD-2076 administered to patients with ovarian clear cell carcinoma: A trial of the Princess Margaret Phase II Consortium. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Martin-Lorente, Cristina
  • Tan, David SP
  • Dhani, Neesha
  • Butler, Marcus
  • Mackay, Helen
  • Wilson, Michelle
  • Lheureux, Stephanie
  • Hirte, Holger
  • Welch, Stephen
  • Weberpals, Johanne Ingrid
  • Prafullg, Ghatage
  • Tonkin, Katia
  • Wang, Lisa
  • Haley, Anna
  • Capobianco, Stephanie
  • Oza, Amit M

publication date

  • May 20, 2014